Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators

US7825260B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Rainer Albert · Basel, CH
• Claus Ehrhardt · Lörrach, DE
• Peter Ettmayer · Wien, AT
• Klaus Hinterding · Kohren-Sahlis, DE
• Klemens Hogenauer · Oberwil, CH
• Peter Nussbaumer · Schwanenstadt, AT

Key dates

• Filing date: Apr 29, 2004
• Grant date: Nov 2, 2010
• Expiry date: Jan 6, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2601/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of formula I,wherein X, a, b, R1, R2, R3, R4 and R5 are as defined in the specification, processes for their production, their uses and pharmaceutical compositions containing them.